[3-(3-chlorophenyl)-1,2,4-oxadiazol-5-yl]methanamine, 95.0%, 2.5g

iScope IS.1152-EPL Biocular with E-plan objectives

2,3-Dibromo-5,6-dimethoxypyridine, 97%, 1g

3-[FLUORO-(3-FLUORO-PHENYL)-METHYL]-BENZOIC ACID, 95.0%, 250mg

4-Fluoro-3-methoxyphenylacetonitrile, 98.0%, 25g

Boc-(�)-trans-4-(2-hydroxyphenyl)pyrrolidine-3-carboxylic acid, 96.0%, 250mg

Bicyclo[1.1.1]pentane-1-carboxylic acid, 95.0%, 500mg

7-(Trifluoromethyl)-3,4-dihydronaphthalen-1(2H)-one, 95.0%, 100mg

Ethyl 2-bromo-2-phenylacetate, 95.0%, 1g

2-Chloro-4-fluorotoluene, 99.0%, 5kg

3-(6-Dimethylamino-4-trifluoromethyl-pyridin-2-yl)-benzaldehyde oxime, 95.0%, 500mg

4-ACETYLAMINO-5-BROMO-2-CHLOROPYRIMIDINE, 95.0%, 250mg

Acid CF3-reagent (Togni Reagent II) 100 g of active ingredient (200 g of mixture)